These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33551210)

  • 41. [Diabetes and COVID-19 in the elderly, harmful symbiosis].
    Formiga F; Tarazona-Santabalbina FJ
    Rev Esp Geriatr Gerontol; 2020; 55(6):315-316. PubMed ID: 32900513
    [No Abstract]   [Full Text] [Related]  

  • 42. Characteristics of SARS-CoV-2 positive cases beyond health-care professionals or social and health-care facilities.
    Deiana G; Azara A; Dettori M; Delogu F; Vargiu G; Gessa I; Arghittu A; Tidore M; Steri G; Castiglia P
    BMC Public Health; 2021 Jan; 21(1):83. PubMed ID: 33413218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality.
    He Q; Zhao MM; Li MJ; Li XY; Jin JM; Feng YM; Zhang L; Huang WJ; Yang F; Yang JK
    Elife; 2024 Aug; 13():. PubMed ID: 39150053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Virtual Inpatient Diabetes Management Service: COVID-19 brings the future to inpatient diabetes management.
    Cheung NW; Hor A; Hng TM
    Med J Aust; 2022 Apr; 216(6):321-322. PubMed ID: 35267199
    [No Abstract]   [Full Text] [Related]  

  • 45. Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily.
    Silverii GA; Monami M; Cernigliaro A; Vigneri E; Guarnotta V; Scondotto S; Allotta VA; Conti M; Giordano C; Mannucci E
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):396-398. PubMed ID: 33223405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions.
    Zaccardi F; Khunti K
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4248-e4249. PubMed ID: 35749295
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 and diabetes: What do we know so far?
    Gangadaran P; Padinjarathil H; Rajendran SHS; Jogalekar MP; Hong CM; Aruchamy B; Rajendran UM; Gurunagarajan S; Krishnan A; Ramani P; Subramanian K
    Exp Biol Med (Maywood); 2022 Aug; 247(15):1330-1334. PubMed ID: 35894117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.
    Pelle MC; Zaffina I; Provenzano M; Moirano G; Arturi F
    Front Endocrinol (Lausanne); 2022; 13():974540. PubMed ID: 36060943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 and diabetes: What have we learned so far?
    Taher N; Huda MS; Chowdhury TA
    Clin Med (Lond); 2020 Jul; 20(4):e87-e90. PubMed ID: 32628128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post-COVID-19 era.
    Choudhary P; Wilmot EG; Owen K; Patel DC; Mills L; Rayman G; Winocour P; Ayman G; Patel R; Hambling C; Nagi DK
    Diabet Med; 2021 Mar; 38(3):e14462. PubMed ID: 33230813
    [No Abstract]   [Full Text] [Related]  

  • 51. Pancreatic β-cell fate in subjects with COVID-19.
    Shirakawa J
    J Diabetes Investig; 2021 Dec; 12(12):2126-2128. PubMed ID: 34529355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
    Fleming N; Sacks LJ; Pham CT; Neoh SL; Ekinci EI
    Diabet Med; 2021 Mar; 38(3):e14509. PubMed ID: 33377213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes Mellitus, Energy Metabolism, and COVID-19.
    Conte C; Cipponeri E; Roden M
    Endocr Rev; 2024 Mar; 45(2):281-308. PubMed ID: 37934800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes Research and Clinical Practice and the fight against COVID-19.
    Ceriello A
    Diabetes Res Clin Pract; 2022 Aug; 190():110025. PubMed ID: 35907506
    [No Abstract]   [Full Text] [Related]  

  • 55. The COVID-19 pandemic may be receding but the diabetes pandemic rages on.
    Mulder H; Fall T
    Diabetologia; 2022 Jun; 65(6):915-916. PubMed ID: 35294579
    [No Abstract]   [Full Text] [Related]  

  • 56. Dissecting the Interrelationship between COVID-19 and Diabetes Mellitus.
    Roham PH; Kamath JJ; Sharma S
    Adv Biol (Weinh); 2023 Aug; 7(8):e2300107. PubMed ID: 37246237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Supporting people with diabetes during a pandemic.
    Skinner T; Speight J
    Diabet Med; 2020 Jul; 37(7):1155-1156. PubMed ID: 32407569
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'.
    Abbasi-Oshaghi E; Mirzaei F; Khodadadi I
    Prim Care Diabetes; 2021 Feb; 15(1):30. PubMed ID: 33162350
    [No Abstract]   [Full Text] [Related]  

  • 59. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes and the COVID-19 pandemic.
    Khunti K; Valabhji J; Misra S
    Diabetologia; 2023 Feb; 66(2):255-266. PubMed ID: 36418578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.